Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Filings indexed 1,067 across all filing types
Latest filing 2016-10-31 Regulatory Filings
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
ASX Market Release - Reinstatement 1 page 84.9KB
Regulatory Filings Classification · 95% confidence The document is a market release announcing the reinstatement of Cellmid Limited's securities to official quotation on the stock exchange. It references compliance with listing rules and mentions a prior capital raising announcement but does not contain financial statements or detailed financial data. The document is short (661 characters) and serves as an official notice rather than a full report. Therefore, it fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance notices that do not fit other specific categories.
2016-10-31 English
Change of Director's Interest Notice - Halasz 3 pages 113.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details changes in securities holdings by a company director, including dates, number of shares before and after the change, and nature of the transaction. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure related to insider trading or director share transactions. There is no financial performance data, earnings information, or report publication. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length and content confirm it is not a brief announcement or a report publication notice but a full notice of director's interest change.
2016-10-31 English
Appendix 4C - quarterly 7 pages 190.1KB
Interim / Quarterly Report Classification · 100% confidence The document is titled as an ASX Announcement and is specifically described as "Notes to Appendix 4C" and an "Appendix 4C Quarterly report for entities subject to Listing Rule 4.7B." Appendix 4C is a standard quarterly cash flow report required by the ASX for listed entities, providing detailed cash flow statements, operational updates, financing activities, and compliance statements. The document contains actual financial data for the quarter ended 30 September 2016, including cash flows from operating, investing, and financing activities, as well as a reconciliation of cash and cash equivalents. It also includes management commentary on operational updates and financing. This matches the definition of an Interim / Quarterly Report (IR), which must contain substantive financial data and analysis for a period shorter than a full fiscal year. The document is not merely an announcement or a certification but a full quarterly financial report. Therefore, the correct classification is IR (Interim / Quarterly Report). Q1 2017
2016-10-30 English
Suspension from Official Quotation 2 pages 223.4KB
Regulatory Filings Classification · 95% confidence The document is a market release dated 28 October 2016 from Cellmid Limited announcing the immediate suspension of its securities from official quotation on the ASX. The text references Listing Rule 17.2 and states the suspension is pending completion of negotiations related to a proposed capital raising. There is no financial data, no detailed report, and the document is short (1617 characters). It is an official announcement about a trading suspension, not a financial report or detailed filing. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2016-10-27 English
Appendix 3B 9 pages 470.0KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement titled 'Appendix 3B New issue announcement' which details the issuance of new shares following the exercise of options. It includes specific information about the number of shares issued, exercise prices, dates, and compliance with ASX rules. Appendix 3B is a standard form used in Australian securities markets to announce new issues of securities and applications for quotation. The content is focused on capital raising and share issuance rather than financial results, management changes, or other report types. It is not a full financial report, earnings release, or management discussion. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and detail support a high confidence classification.
2016-10-27 English
Ceasing to be a substantial holder 1 page 72.0KB
Regulatory Filings Classification · 90% confidence The document text is extremely short (364 characters) and contains no meaningful textual content, only placeholders for omitted pictures and some nonsensical tabular data. There is no indication of any report type, financial data, regulatory references, or announcements. Given the lack of substantive content and the presence of only images or placeholders, this document does not fit any specific report category. According to the rules, when a document does not fit any specific category and lacks content, it should be classified as a Regulatory Filing (RNS) as a fallback category.
2016-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.